Submission Details
| 510(k) Number | K142064 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 30, 2014 |
| Decision Date | February 13, 2015 |
| Days to Decision | 198 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K142064 is an FDA 510(k) clearance for the GALILEO NT, a Non-normalizing Quantitative Electroencephalograph Software (Class II — Special Controls, product code OLT), submitted by Eb Neuro S.P.A. (Indianpolis, US). The FDA issued a Cleared decision on February 13, 2015, 198 days after receiving the submission on July 30, 2014. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1400.
| 510(k) Number | K142064 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 30, 2014 |
| Decision Date | February 13, 2015 |
| Days to Decision | 198 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | OLT — Non-normalizing Quantitative Electroencephalograph Software |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1400 |
| Definition | Analyze Electroencephalograph Data Using Conventional Methodology To Output And Display Standard Electroencephalograph Parameters For Interpretation By A Qualified User. |